Anti-immunoglobulin	B-protein
M	I-protein
activates	O
nuclear	B-protein
calcium/calmodulin-dependent	I-protein
protein	I-protein
kinase	I-protein
II	I-protein
in	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

We	O
and	O
others	O
have	O
previously	O
shown	O
that	O
the	O
nuclear	B-protein
protein	I-protein
,	O
Ets-1	B-protein
,	O
is	O
phosphorylated	O
in	O
a	O
calcium-dependent	O
manner	O
after	O
ligation	O
of	O
immunoglobulin	O
(	O
Ig	O
)	O
M	O
on	O
B	B-cell_type
lymphocytes	I-cell_type
.	O

As	O
this	O
phosphorylation	O
was	O
independent	O
of	O
protein	B-protein
kinase	I-protein
C	I-protein
activity	O
,	O
we	O
tested	O
whether	O
a	O
calcium/calmodulin-dependent	B-protein
protein	I-protein
kinase	I-protein
(	O
CaM	B-protein
kinase	I-protein
)	O
might	O
phosphorylate	O
the	O
Ets-1	B-protein
protein	I-protein
after	O
elevation	O
of	O
intracellular	O
free	O
calcium	O
concentrations	O
.	O

The	O
dephosphorylated	O
form	O
of	O
Ets-1	B-protein
has	O
been	O
shown	O
to	O
bind	O
to	O
chromatin	O
,	O
suggesting	O
that	O
the	O
operative	B-protein
kinase	I-protein
should	O
be	O
detectable	O
in	O
the	O
nucleus	O
.	O

We	O
prepared	O
nuclear	O
extracts	O
from	O
two	O
human	B-cell_line
B	I-cell_line
cell	I-cell_line
lines	I-cell_line
in	O
which	O
increased	O
intracellular	O
free	O
calcium	O
levels	O
correlated	O
with	O
increased	O
phosphorylation	O
of	O
the	O
Ets-1	B-protein
protein	O
.	O

Activity	O
of	O
the	O
CaM	B-protein
kinases	I-protein
was	O
determined	O
using	O
a	O
synthetic	O
peptide	O
substrate	O
both	O
in	O
the	O
absence	O
and	O
presence	O
of	O
an	O
inhibitor	O
specific	O
for	O
the	O
CaM	B-protein
kinase	I-protein
family	I-protein
,	O
KN-62	O
.	O

Stimulation	O
of	O
cells	O
with	O
anti-IgM	B-protein
led	O
to	O
increased	O
activity	O
of	O
a	O
nuclear	B-protein
kinase	I-protein
that	O
could	O
phosphorylate	O
the	O
peptide	O
,	O
and	O
this	O
activity	O
was	O
reduced	O
by	O
10	O
microM	O
KN-62	O
.	O

Kinase	O
activity	O
was	O
reduced	O
in	O
lysates	O
preadsorbed	O
using	O
an	O
antibody	B-protein
specific	O
for	O
CaM	B-protein
kinase	I-protein
II	I-protein
.	O

Two-dimensional	O
phosphopeptide	O
maps	O
of	O
the	O
Ets-1	B-protein
protein	O
from	O
cells	O
incubated	O
with	O
ionomycin	O
or	O
anti-IgM	B-protein
contained	O
two	O
unique	O
phosphopeptides	O
that	O
were	O
absent	O
in	O
untreated	O
cells	O
.	O

Incubation	O
of	O
isolated	B-protein
Ets-1	I-protein
protein	I-protein
with	O
purified	O
CaM	B-protein
kinase	I-protein
II	I-protein
produced	O
phosphorylation	O
of	O
peptides	O
that	O
migrated	O
identically	O
to	O
those	O
found	O
in	O
cells	O
incubated	O
with	O
either	O
anti-IgM	B-protein
or	O
ionomycin	O
.	O

These	O
data	O
suggest	O
a	O
model	O
of	O
signal	O
transduction	O
by	O
the	O
antigen	B-protein
receptor	I-protein
on	O
B	B-cell_type
lymphocytes	I-cell_type
in	O
which	O
increased	O
intracellular	O
free	O
calcium	O
can	O
rapidly	O
activate	O
nuclear	B-protein
CaM	I-protein
kinase	I-protein
II	I-protein
,	O
potentially	O
resulting	O
in	O
phosphorylation	O
and	O
regulation	O
of	O
DNA-binding	B-protein
proteins	I-protein
.	O

Anti-Immunoglobulin	NULL
M	NULL
Activates	NULL
Nuclear	NULL
Calcium	NULL
/Calmodulin-dependent	NULL
Protein	NULL
Kinase	NULL
II	NULL
in	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
By	NULL
Mary	NULL
A.	NULL
Valentine	NULL
,	NULL
*	NULL
Andrew	NULL
J.	NULL
Czernik	NULL
,	NULL
$	NULL
Nisa	NULL
Rachie	NULL
,	NULL
}	NULL
Hiroyoshi	NULL
Hidaka	NULL
,	NULL
Constance	NULL
L.	NULL
Fisher	NULL
,	NULL
``	NULL
John	NULL
C.	NULL
Cambier	NULL
,	NULL
``	NULL
and	NULL
Karol	NULL
Bomsztykt	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
*Microbiology	NULL
and	NULL
*	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98195	NULL
;	NULL
$	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Neuroscience	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
10021-6399	NULL
;	NULL
Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Nagoya	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nagoya	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80206-2762	NULL
Summary	NULL
We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
nuclear	NULL
protein	NULL
,	NULL
Ets-1	NULL
,	NULL
is	NULL
phosphorylated	NULL
in	NULL
a	NULL
calcium-dependent	NULL
manner	NULL
after	NULL
ligation	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
M	NULL
on	NULL
B	NULL
lymphocytes	NULL
.	NULL

As	NULL
this	NULL
phosphorylation	NULL
was	NULL
independent	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
a	NULL
calcium/	NULL
calmodulin-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
CaM	NULL
kinase	NULL
)	NULL
might	NULL
phosphorylate	NULL
the	NULL
Ets-1	NULL
protein	NULL
after	NULL
elevation	NULL
of	NULL
intracellular	NULL
free	NULL
calcium	NULL
concentrations	NULL
.	NULL

The	NULL
dephosphorylated	NULL
form	NULL
of	NULL
Ets-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
chromatin	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
operative	NULL
kinase	NULL
should	NULL
be	NULL
detectable	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

We	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
two	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
in	NULL
which	NULL
increased	NULL
intracellular	NULL
free	NULL
calcium	NULL
levels	NULL
correlated	NULL
with	NULL
increased	NULL
phosphorylation	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
CaM	NULL
kinases	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
synthetic	NULL
peptide	NULL
substrate	NULL
both	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
an	NULL
inhibitor	NULL
specific	NULL
for	NULL
the	NULL
CaM	NULL
kinase	NULL
family	NULL
,	NULL
KN-62	NULL
.	NULL

Stimulation	NULL
of	NULL
cells	NULL
with	NULL
anti-IgM	NULL
led	NULL
to	NULL
increased	NULL
activity	NULL
of	NULL
a	NULL
nuclear	NULL
kinase	NULL
that	NULL
could	NULL
phosphorylate	NULL
the	NULL
peptide	NULL
,	NULL
and	NULL
this	NULL
activity	NULL
was	NULL
reduced	NULL
by	NULL
10	NULL
M	NULL
KN-62	NULL
.	NULL

Kinase	NULL
activity	NULL
was	NULL
reduced	NULL
in	NULL
lysates	NULL
preadsorbed	NULL
using	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
CaM	NULL
kinase	NULL
II	NULL
.	NULL

Two-dimensional	NULL
phosphopeptide	NULL
maps	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
from	NULL
cells	NULL
incubated	NULL
with	NULL
ionomycin	NULL
or	NULL
anti-IgM	NULL
contained	NULL
two	NULL
unique	NULL
phosphopeptides	NULL
that	NULL
were	NULL
absent	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

Incubation	NULL
of	NULL
isolated	NULL
Ets-1	NULL
protein	NULL
with	NULL
purified	NULL
CaM	NULL
kinase	NULL
II	NULL
produced	NULL
phosphorylation	NULL
of	NULL
peptides	NULL
that	NULL
migrated	NULL
identically	NULL
to	NULL
those	NULL
found	NULL
in	NULL
cells	NULL
incubated	NULL
with	NULL
either	NULL
anti-IgM	NULL
or	NULL
ionomycin	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
a	NULL
model	NULL
of	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
antigen	NULL
receptor	NULL
on	NULL
B	NULL
lymphocytes	NULL
in	NULL
which	NULL
increased	NULL
intracellular	NULL
free	NULL
calcium	NULL
can	NULL
rapidly	NULL
activate	NULL
nuclear	NULL
CaM	NULL
kinase	NULL
II	NULL
,	NULL
potentially	NULL
resulting	NULL
in	NULL
phosphorylation	NULL
and	NULL
regulation	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

he	NULL
means	NULL
by	NULL
which	NULL
ligation	NULL
of	NULL
surface	NULL
proteins	NULL
regu-	NULL
lates	NULL
the	NULL
function	NULL
of	NULL
nuclear	NULL
DNA-binding	NULL
proteins	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

Among	NULL
potential	NULL
mechanisms	NULL
that	NULL
modulate	NULL
the	NULL
activity	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
the	NULL
best	NULL
studied	NULL
is	NULL
phosphorylation	NULL
(	NULL
for	NULL
review	NULL
see	NULL
reference	NULL
1	NULL
)	NULL
.	NULL

Several	NULL
protein	NULL
serine/threonine	NULL
kinases	NULL
are	NULL
reported	NULL
to	NULL
function	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
including	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
,	NULL
``	NULL
casein	NULL
kinase	NULL
II	NULL
,	NULL
the	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKA	NULL
)	NULL
,	NULL
and	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
calcium/calmodulin-dependent	NULL
kinases	NULL
(	NULL
CaM	NULL
'	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
[	NULL
Ca	NULL
``	NULL
*	NULL
]	NULL
;	NULL
,	NULL
intracellular	NULL
free	NULL
calcium	NULL
;	NULL
CaM	NULL
kinase	NULL
,	NULL
calcium/calmodulin-dependent	NULL
kinase	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
MLCK	NULL
,	NULL
myosin	NULL
light	NULL
chain	NULL
kinase	NULL
;	NULL
PKA	NULL
,	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PKI	NULL
,	NULL
peptide	NULL
inhibitor	NULL
of	NULL
PKA	NULL
;	NULL
PVDF	NULL
,	NULL
polyvinylidene	NULL
difluoride	NULL
.	NULL

1943	NULL
kinases	NULL
)	NULL
(	NULL
see	NULL
reference	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
microtubule-associated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
and	NULL
p90®	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
after	NULL
activation	NULL
of	NULL
HeLa	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Once	NULL
activated	NULL
,	NULL
nuclear	NULL
kinases	NULL
can	NULL
phosphorylate	NULL
specific	NULL
DNA-binding	NULL
proteins	NULL
and	NULL
alter	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
proteins	NULL
to	NULL
interact	NULL
with	NULL
DNA	NULL
or	NULL
other	NULL
nuclear	NULL
proteins	NULL
with	NULL
which	NULL
they	NULL
form	NULL
functional	NULL
complexes	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
the	NULL
nuclear	NULL
protein	NULL
Ets-1	NULL
is	NULL
phosphorylated	NULL
in	NULL
B	NULL
lymphocytes	NULL
after	NULL
ligation	NULL
of	NULL
the	NULL
antigen	NULL
receptor	NULL
on	NULL
B	NULL
cells	NULL
,	NULL
surface	NULL
IgM	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
occurred	NULL
in	NULL
a	NULL
calcium-dependent	NULL
manner	NULL
and	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
involve	NULL
the	NULL
calcium-regulated	NULL
protein	NULL
kinase	NULL
,	NULL
PKC	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Observations	NULL
that	NULL
the	NULL
Ets-1	NULL
protein	NULL
associates	NULL
with	NULL
DNA	NULL
only	NULL
in	NULL
its	NULL
unphosphorylated	NULL
state	NULL
(	NULL
4	NULL
)	NULL
and	NULL
that	NULL
calcium	NULL
ionophore	NULL
specifically	NULL
increased	NULL
Ets-1	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/95/12/1943/07	NULL
$	NULL
2.00	NULL
Volume	NULL
182	NULL
December	NULL
1995	NULL
1943-1949	NULL
phosphorylation	NULL
on	NULL
seryl	NULL
and	NULL
threonyl	NULL
residues	NULL
(	NULL
5	NULL
)	NULL
predicted	NULL
the	NULL
presence	NULL
a	NULL
nuclear	NULL
protein	NULL
serine/threonine	NULL
kinase	NULL
that	NULL
might	NULL
be	NULL
regulated	NULL
directly	NULL
by	NULL
calcium	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
at	NULL
least	NULL
two	NULL
families	NULL
of	NULL
calcium-regulated	NULL
kinases	NULL
are	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
:	NULL
the	NULL
calcium-dependent	NULL
isoforms	NULL
of	NULL
PKC	NULL
and	NULL
the	NULL
CaM	NULL
kinases	NULL
,	NULL
including	NULL
myosin	NULL
light	NULL
chain	NULL
kinase	NULL
(	NULL
MLCK	NULL
)	NULL
(	NULL
for	NULL
review	NULL
see	NULL
reference	NULL
6	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
MLCK	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
use	NULL
only	NULL
myosin	NULL
light	NULL
chains	NULL
as	NULL
a	NULL
physiologically	NULL
significant	NULL
substrate	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
a	NULL
CaM	NULL
kinase	NULL
could	NULL
be	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
whether	NULL
ligation	NULL
of	NULL
surface	NULL
IgM	NULL
would	NULL
activate	NULL
that	NULL
kinase	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
.	NULL

-	NULL
The	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
Raji	NULL
,	NULL
T5-1	NULL
,	NULL
and	NULL
Ramos	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyruvate	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
nonessential	NULL
amino	NULL
acids	NULL
,	NULL
penicillin	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
log	NULL
phase	NULL
before	NULL
use	NULL
in	NULL
the	NULL
ex-periment	NULL
.	NULL

Reagents	NULL
.	NULL

-	NULL
The	NULL
protease	NULL
inhibitors	NULL
PMSF	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
apro-tinin	NULL
were	NULL
purchased	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
Corp.	NULL
(	NULL
Indiana-polis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
and	NULL
N-tosyl	NULL
--	NULL
phenylalanine	NULL
chloromethyl	NULL
ketone-treated	NULL
trypsin	NULL
was	NULL
purchased	NULL
from	NULL
Worthington	NULL
Biochemical	NULL
Corp.	NULL
(	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
Corp.	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
cellulose	NULL
TLC	NULL
plates	NULL
were	NULL
obtained	NULL
from	NULL
Merck	NULL
(	NULL
Darmstadt	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Antibodies	NULL
specific	NULL
for	NULL
the	NULL
Ets-1	NULL
protein	NULL
were	NULL
produced	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
control	NULL
MOPC	NULL
21	NULL
antibody	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

A	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
2	NULL
goat	NULL
anti-human	NULL
IgG	NULL
and	NULL
IgM	NULL
was	NULL
purchased	NULL
from	NULL
Jackson	NULL
ImmunoRe-search	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
(	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
and	NULL
used	NULL
for	NULL
all	NULL
anti-IgM	NULL
stimulations	NULL
.	NULL

The	NULL
antibody	NULL
RU16	NULL
was	NULL
made	NULL
using	NULL
a	NULL
peptide	NULL
corresponding	NULL
to	NULL
the	NULL
B	NULL
subunit	NULL
residues	NULL
506-531	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
;	NULL
this	NULL
antibody	NULL
detects	NULL
both	NULL
e	NULL
and	NULL
B/B	NULL
'	NULL
subunits	NULL
on	NULL
immuno-blots	NULL
of	NULL
total	NULL
rat	NULL
forebrain	NULL
homogenates	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
peptide	NULL
substrate	NULL
,	NULL
syntide	NULL
(	NULL
PLARTLSVAGLPGKK	NULL
)	NULL
(	NULL
9	NULL
)	NULL
,	NULL
PKI	NULL
,	NULL
a	NULL
peptide	NULL
inhibitor	NULL
of	NULL
PKA	NULL
(	NULL
TTYADFIASGRTGRRNAIHD	NULL
)	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CaM	NULL
kinase	NULL
II	NULL
inhibitor	NULL
peptide	NULL
a	NULL
subunit	NULL
residues	NULL
(	NULL
281-309	NULL
)	NULL
(	NULL
MHRQETVDCLKKFNARRKLKGAILTTMLA	NULL
)	NULL
(	NULL
11	NULL
)	NULL
-	NULL
were	NULL
synthesized	NULL
at	NULL
the	NULL
Howard	NULL
Hughes	NULL
Chemical	NULL
Synthesis	NULL
Facility	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Purified	NULL
CaM	NULL
kinase	NULL
II	NULL
was	NULL
either	NULL
isolated	NULL
from	NULL
rat	NULL
forebrain	NULL
(	NULL
12	NULL
)	NULL
or	NULL
was	NULL
generously	NULL
supplied	NULL
by	NULL
Dr.	NULL
Natalie	NULL
Ahn	NULL
.	NULL

The	NULL
CaM	NULL
kinase	NULL
inhibitor	NULL
KN-62	NULL
was	NULL
synthesized	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
.	NULL

-	NULL
For	NULL
metabolic	NULL
labeling	NULL
studies	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
*PJorthophosphate	NULL
for	NULL
3-5	NULL
h	NULL
at	NULL
37°C	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
in	NULL
PBS/0.1	NULL
%	NULL
azide	NULL
and	NULL
lysed	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
precleared	NULL
twice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
appropriate	NULL
antibodies	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Adherent	NULL
complexes	NULL
were	NULL
eluted	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
12.5	NULL
%	NULL
polyacrylamide	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Preparation	NULL
of	NULL
Cell	NULL
Extracts	NULL
.	NULL

-	NULL
For	NULL
kinase	NULL
assays	NULL
of	NULL
whole-cell	NULL
extracts	NULL
,	NULL
duplicate	NULL
cell	NULL
suspensions	NULL
(	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
assay	NULL
point	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
,	NULL
ionomycin	NULL
(	NULL
1	NULL
M	NULL
)	NULL
,	NULL
or	NULL
50	NULL
pg/ml	NULL
of	NULL
anti-IgM	NULL
for	NULL
various	NULL
times	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pelleted	NULL
for	NULL
10	NULL
s	NULL
(	NULL
13,000	NULL
g	NULL
)	NULL
,	NULL
and	NULL
the	NULL
stimulation	NULL
was	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
ice-cold	NULL
PBS/0.01	NULL
%	NULL
azide	NULL
.	NULL

The	NULL
cellular	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
0.3	NULL
mi	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
and	NULL
80	NULL
mM	NULL
B-glycerophos-phate	NULL
)	NULL
.	NULL

This	NULL
buffer	NULL
and	NULL
all	NULL
other	NULL
buffers	NULL
contained	NULL
the	NULL
following	NULL
pro	NULL
1944	NULL
tease	NULL
inhibitors	NULL
,	NULL
added	NULL
just	NULL
before	NULL
use	NULL
:	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
50	NULL
pg/ml	NULL
apro-tinin	NULL
,	NULL
2	NULL
ug/ml	NULL
peptstatin	NULL
,	NULL
and	NULL
1	NULL
pg/ml	NULL
leupeptin	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
three	NULL
1-s	NULL
bursts	NULL
using	NULL
a	NULL
probe	NULL
sonicator	NULL
(	NULL
Bo	NULL
Braun	NULL
Bio-tech	NULL
Intl	NULL
.	NULL

,	NULL
Allentown	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Soluble	NULL
and	NULL
particulate	NULL
fractions	NULL
were	NULL
separated	NULL
by	NULL
centrifugation	NULL
for	NULL
20	NULL
min	NULL
(	NULL
100,000	NULL
g	NULL
,	NULL
4°C	NULL
)	NULL
using	NULL
a	NULL
centrifuge	NULL
(	NULL
model	NULL
TL-100	NULL
;	NULL
Beckman	NULL
Instruments	NULL
,	NULL
Inc.	NULL
,	NULL
Fullerton	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
assayed	NULL
the	NULL
same	NULL
day	NULL
or	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
assay	NULL
.	NULL

Extracts	NULL
from	NULL
both	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
compartments	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
1-5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
1	NULL
ml	NULL
PBS	NULL
and	NULL
once	NULL
with	NULL
1	NULL
ml	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
Hepes	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
4°C	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
suspending	NULL
the	NULL
cell	NULL
pellet	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
pl/10	NULL
``	NULL
cells	NULL
)	NULL
containing	NULL
0.1	NULL
%	NULL
NP-40	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

To	NULL
isolate	NULL
nuclei	NULL
,	NULL
the	NULL
lysate	NULL
was	NULL
vigorously	NULL
mixed	NULL
and	NULL
microcentrifuged	NULL
(	NULL
10	NULL
min	NULL
at	NULL
12,000	NULL
rpm	NULL
,	NULL
4°C	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
pellet	NULL
was	NULL
washed	NULL
once	NULL
with	NULL
1	NULL
ml	NULL
lysis	NULL
buffer	NULL
without	NULL
NP-40	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
by	NULL
resuspending	NULL
the	NULL
nuclear	NULL
pellet	NULL
in	NULL
extraction	NULL
buffer	NULL
(	NULL
20	NULL
pl/10	NULL
``	NULL
cells	NULL
)	NULL
(	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
1.5	NULL
MgCb	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
pH	NULL
7.9	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
vigorous	NULL
mixing	NULL
,	NULL
the	NULL
nuclear	NULL
suspension	NULL
was	NULL
microcentrifuged	NULL
(	NULL
10	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
discarded	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
microcentrifuged	NULL
as	NULL
before	NULL
(	NULL
5	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
.	NULL

Supernatant	NULL
fluid	NULL
from	NULL
the	NULL
second	NULL
centrifugation	NULL
was	NULL
diluted	NULL
(	NULL
30	NULL
pl/10	NULL
``	NULL
cells	NULL
)	NULL
in	NULL
dilution	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
concentration	NULL
was	NULL
measured	NULL
(	NULL
Micro	NULL
BCA	NULL
protein	NULL
assay	NULL
;	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

DTT	NULL
(	NULL
0.5	NULL
mM	NULL
)	NULL
,	NULL
PMSF	NULL
(	NULL
0.5	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
leupeptin	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
were	NULL
added	NULL
to	NULL
both	NULL
lysis	NULL
and	NULL
extraction	NULL
buffers	NULL
just	NULL
before	NULL
use	NULL
.	NULL

The	NULL
diluting	NULL
buffer	NULL
contained	NULL
the	NULL
same	NULL
amounts	NULL
of	NULL
DTT	NULL
and	NULL
leupeptin	NULL
,	NULL
but	NULL
only	NULL
0.2	NULL
mM	NULL
PMSF	NULL
.	NULL

All	NULL
buffers	NULL
contained	NULL
the	NULL
following	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
all	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
:	NULL
30	NULL
mM	NULL
p-nitrophenyl	NULL
phosphate	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
0.1	NULL
mM	NULL
Na	NULL
,	NULL
VO,4	NULL
,	NULL
0.1	NULL
mM	NULL
Na	NULL
,	NULL
MoQ	NULL
,	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
B-glycerophosphate	NULL
.	NULL

Samples	NULL
were	NULL
stored	NULL
at	NULL
-70°C	NULL
or	NULL
assayed	NULL
the	NULL
same	NULL
day	NULL
as	NULL
pre-pared	NULL
.	NULL

Purity	NULL
of	NULL
the	NULL
nuclear	NULL
preparations	NULL
was	NULL
monitored	NULL
by	NULL
measuring	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytosolic	NULL
enzyme	NULL
lactate	NULL
dehydro-genase	NULL
.	NULL

Lactate	NULL
dehydrogenase	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
represented	NULL
1-10	NULL
%	NULL
of	NULL
the	NULL
total	NULL
enzymatic	NULL
activity	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

Recovery	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
was	NULL
in	NULL
the	NULL
range	NULL
of	NULL
0.5-0.7	NULL
mg	NULL
.	NULL

In	NULL
Vitro	NULL
Phosphorylation	NULL
by	NULL
Purified	NULL
CaM	NULL
Kinase	NULL
II	NULL
.	NULL

|	NULL
Ets-1	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
kept	NULL
on	NULL
solid	NULL
phase	NULL
(	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
resuspended	NULL
in	NULL
assay	NULL
buffer	NULL
consisting	NULL
of	NULL
50	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
50	NULL
pM	NULL
cold	NULL
ATP	NULL
,	NULL
50	NULL
M	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
(	NULL
~1,000	NULL
cpm/	NULL
pmol	NULL
)	NULL
,	NULL
1	NULL
wM	NULL
calmodulin	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
CaCl	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
started	NULL
by	NULL
addition	NULL
of	NULL
75	NULL
ng/m	NULL
!	NULL

of	NULL
rat	NULL
forebrain	NULL
CaM	NULL
kinase	NULL
II	NULL
(	NULL
sp	NULL
act	NULL
=	NULL
2.4	NULL
pumol/min	NULL
per	NULL
mg	NULL
protein	NULL
using	NULL
the	NULL
syntide	NULL
peptide	NULL
as	NULL
substrate	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
proceeded	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
and	NULL
was	NULL
terminated	NULL
by	NULL
washing	NULL
the	NULL
pellet	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
boiling	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Phosphoproteins	NULL
were	NULL
identified	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
.	NULL

Protein	NULL
Kinase	NULL
Assays	NULL
.	NULL

-	NULL
CaM	NULL
kinase	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
in	NULL
vitro	NULL
activators	NULL
was	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
assay	NULL
buffer	NULL
consisting	NULL
of	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.02	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PKI	NULL
peptide	NULL
,	NULL
50	NULL
wM	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
(	NULL
~1,000	NULL
cpm/pmol	NULL
)	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
.	NULL

When	NULL
used	NULL
,	NULL
the	NULL
peptide	NULL
substrate	NULL
syntide	NULL
was	NULL
present	NULL
at	NULL
200	NULL
M.	NULL
Kinase	NULL
assays	NULL
were	NULL
initiated	NULL
by	NULL
addition	NULL
of	NULL
enzyme	NULL
samples	NULL
to	NULL
give	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
10-15	NULL
min	NULL
at	NULL
30°C	NULL
and	NULL
transferred	NULL
to	NULL
p81	NULL
phosphocellulose	NULL
paper	NULL
,	NULL
and	NULL
the	NULL
papers	NULL
were	NULL
washed	NULL
extensively	NULL
.	NULL

Phosphorylation	NULL
of	NULL
peptide	NULL
substrates	NULL
was	NULL
quantified	NULL
by	NULL
measure	NULL
Anti-IgM	NULL
Activation	NULL
of	NULL
Nuclear	NULL
CaM	NULL
Kinase	NULL
II	NULL
ment	NULL
of	NULL
Cerenkov	NULL
radiation	NULL
using	NULL
a	NULL
beta	NULL
counter	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
substrate	NULL
was	NULL
subtracted	NULL
from	NULL
the	NULL
mean	NULL
of	NULL
duplicate	NULL
or	NULL
triplicate	NULL
samples	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
substrate	NULL
to	NULL
yield	NULL
net	NULL
kinase	NULL
activity	NULL
.	NULL

Assay	NULL
results	NULL
were	NULL
standardized	NULL
to	NULL
the	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
samples	NULL
as	NULL
determined	NULL
using	NULL
BCA	NULL
reagent	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
)	NULL
with	NULL
BSA	NULL
as	NULL
standard	NULL
.	NULL

The	NULL
incubation	NULL
times	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
used	NULL
in	NULL
all	NULL
reactions	NULL
were	NULL
previously	NULL
established	NULL
to	NULL
be	NULL
linear	NULL
for	NULL
syntide	NULL
phosphorylation	NULL
.	NULL

Typically	NULL
,	NULL
extracts	NULL
were	NULL
diluted	NULL
to	NULL
1:5	NULL
or	NULL
1:10	NULL
in	NULL
these	NULL
assays	NULL
.	NULL

Immunoblotting	NULL
.	NULL

-	NULL
Equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
cell	NULL
lysates	NULL
,	NULL
nu-clear	NULL
,	NULL
or	NULL
cytosolic	NULL
preparations	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
,	NULL
and	NULL
subsequently	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
(	NULL
PVDF	NULL
)	NULL
membranes	NULL
(	NULL
Immobilon	NULL
;	NULL
Millipore	NULL
Corp.	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
blocked	NULL
for	NULL
30	NULL
min	NULL
using	NULL
BLOTTO	NULL
(	NULL
2	NULL
%	NULL
dried	NULL
milk/PBS	NULL
$	NULL
/0.005	NULL
%	NULL
Tween-100	NULL
)	NULL
and	NULL
incubated	NULL
overnight	NULL
with	NULL
the	NULL
appropriate	NULL
antibody	NULL
.	NULL

After	NULL
two	NULL
10-min	NULL
washes	NULL
with	NULL
BLOTTO	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
1:100	NULL
dilution	NULL
of	NULL
'**I-labeled	NULL
protein	NULL
A	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
or	NULL
by	NULL
use	NULL
of	NULL
a	NULL
phosphorimager	NULL
.	NULL

Phosphopeptide	NULL
Mapping	NULL
.	NULL

-	NULL
Phosphopeptide	NULL
mapping	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
protein	NULL
band	NULL
of	NULL
interest	NULL
was	NULL
excised	NULL
from	NULL
dried	NULL
gels	NULL
,	NULL
washed	NULL
extensively	NULL
,	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
37°C	NULL
with	NULL
150	NULL
ug	NULL
of	NULL
TPCK-trypsin	NULL
.	NULL

Peptides	NULL
were	NULL
dried	NULL
,	NULL
redissolved	NULL
in	NULL
electrophoresis	NULL
buffer	NULL
(	NULL
acetic	NULL
acid/	NULL
formic	NULL
acid/water	NULL
8:2	NULL
:	NULL
90	NULL
,	NULL
pH	NULL
1.9	NULL
)	NULL
and	NULL
spotted	NULL
on	NULL
a	NULL
TLC	NULL
plate	NULL
before	NULL
electrophoresis	NULL
.	NULL

The	NULL
plate	NULL
was	NULL
dried	NULL
overnight	NULL
and	NULL
the	NULL
peptides	NULL
were	NULL
allowed	NULL
to	NULL
separate	NULL
by	NULL
ascending	NULL
chromatography	NULL
for	NULL
6	NULL
h	NULL
before	NULL
autoradiography	NULL
.	NULL

Confirmation	NULL
of	NULL
peptide	NULL
identity	NULL
after	NULL
various	NULL
treatments	NULL
was	NULL
performed	NULL
by	NULL
removing	NULL
labeled	NULL
peptide	NULL
from	NULL
the	NULL
plates	NULL
,	NULL
measuring	NULL
the	NULL
radioactivity	NULL
of	NULL
each	NULL
sample	NULL
by	NULL
Cerenkov	NULL
counting	NULL
,	NULL
and	NULL
subsequent	NULL
mixing	NULL
of	NULL
equal	NULL
cpm	NULL
from	NULL
the	NULL
samples	NULL
.	NULL

These	NULL
mixtures	NULL
were	NULL
then	NULL
reanalyzed	NULL
by	NULL
the	NULL
two-dimensional	NULL
analysis	NULL
detailed	NULL
above	NULL
.	NULL

Results	NULL
Tonomycin	NULL
,	NULL
Anti-IgM	NULL
,	NULL
and	NULL
CaM	NULL
kinase	NULL
II	NULL
Induce	NULL
Increased	NULL
Phosphorylation	NULL
of	NULL
Ets-1	NULL
Tryptic	NULL
Peptides	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
the	NULL
nuclear	NULL
Ets-1	NULL
protein	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
deduced	NULL
sequence	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
predicts	NULL
at	NULL
least	NULL
two	NULL
consensus	NULL
recognition	NULL
sequences	NULL
for	NULL
CaM	NULL
kinase	NULL
II	NULL
phosphorylation	NULL
in	NULL
the	NULL
molecule	NULL
(	NULL
Thr-73	NULL
and	NULL
Ser-156	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

To	NULL
pursue	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
phosphorylation	NULL
,	NULL
we	NULL
identified	NULL
two	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
T5-1	NULL
and	NULL
Raji	NULL
,	NULL
that	NULL
demonstrated	NULL
increased	NULL
phophor-ylation	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
(	NULL
3.6-fold	NULL
over	NULL
control	NULL
for	NULL
anti-IgM	NULL
)	NULL
in	NULL
response	NULL
to	NULL
increased	NULL
calcium	NULL
levels	NULL
.	NULL

Both	NULL
cell	NULL
lines	NULL
respond	NULL
with	NULL
increased	NULL
(	NULL
[	NULL
Ca	NULL
``	NULL
*	NULL
]	NULL
;	NULL
)	NULL
after	NULL
incubation	NULL
with	NULL
anti-IgM	NULL
(	NULL
20	NULL
and	NULL
Valentine	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
CaM	NULL
kinase	NULL
II	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
phosphorylation	NULL
of	NULL
Ets-1	NULL
in	NULL
response	NULL
to	NULL
elevation	NULL
of	NULL
[	NULL
Ca**	NULL
]	NULL
;	NULL
,	NULL
Raji	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
ionomycin	NULL
,	NULL
or	NULL
anti-IgM	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Both	NULL
ionomycin	NULL
and	NULL
anti-IgM	NULL
induced	NULL
increased	NULL
phosphorylation	NULL
of	NULL
two	NULL
distinct	NULL
peptides	NULL
that	NULL
were	NULL
not	NULL
phosphorylated	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
peptides	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Peptide	NULL
2	NULL
was	NULL
faintly	NULL
distinguishable	NULL
in	NULL
the	NULL
untreated	NULL
control	NULL
sample	NULL
,	NULL
accounting	NULL
for	NULL
2	NULL
%	NULL
of	NULL
the	NULL
total	NULL
radioactivity	NULL
in	NULL
the	NULL
sample	NULL
as	NULL
quantified	NULL
with	NULL
the	NULL
use	NULL
of	NULL
the	NULL
phosphorimager	NULL
.	NULL

Phosphorylation	NULL
of	NULL
this	NULL
peptide	NULL
was	NULL
increased	NULL
slightly	NULL
(	NULL
ac-counting	NULL
for	NULL
5-9	NULL
%	NULL
of	NULL
total	NULL
cpm	NULL
)	NULL
in	NULL
all	NULL
other	NULL
samples	NULL
.	NULL

When	NULL
1945	NULL
Valentine	NULL
et	NULL
al	NULL
.	NULL

amz-lgu	NULL
2	NULL
diwali	NULL
lonomycan	NULL
CaM	NULL
Kil	NULL
B	NULL
e	NULL
|	NULL
&	NULL
a	NULL
|	NULL
J	NULL
peptide	NULL
1	NULL
*	NULL
pegs	NULL
=	NULL
pestde	NULL
s	NULL
Figure	NULL
1.	NULL
.	NULL

Ionomycin	NULL
and	NULL
anti-IgM	NULL
induce	NULL
phosphorylation	NULL
on	NULL
the	NULL
Ets-1	NULL
protein	NULL
.	NULL

The	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
Raji	NULL
was	NULL
metabolically	NULL
labeled	NULL
with	NULL
[	NULL
*PJorthophosphate	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
medium	NULL
,	NULL
1	NULL
pM	NULL
ionomycin	NULL
,	NULL
or	NULL
anti-IgM	NULL
(	NULL
50	NULL
ug/ml	NULL
;	NULL
anti-p.	NULL
)	NULL
for	NULL
5	NULL
min	NULL
before	NULL
being	NULL
washed	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-Ets-1	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
10	NULL
%	NULL
gels	NULL
,	NULL
reducing	NULL
conditions	NULL
)	NULL
.	NULL

Ets-1	NULL
proteins	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gels	NULL
and	NULL
analyzed	NULL
by	NULL
two-dimensional	NULL
phosphopeptide	NULL
mapping	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
(	NULL
4	NULL
)	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
purified	NULL
CaM	NULL
kinase	NULL
II	NULL
was	NULL
incubated	NULL
with	NULL
unlabeled	NULL
Ets-1	NULL
proteins	NULL
bound	NULL
to	NULL
Sepharose	NULL
beads	NULL
using	NULL
phosphorylating	NULL
conditions	NULL
;	NULL
the	NULL
proteins	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
solid	NULL
phase	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
position	NULL
of	NULL
the	NULL
origin	NULL
is	NULL
marked	NULL
.	NULL

Increased	NULL
phosphorylation	NULL
of	NULL
three	NULL
peptides	NULL
was	NULL
quantified	NULL
using	NULL
a	NULL
phosphorimager	NULL
.	NULL

Phosphopeptide	NULL
1	NULL
was	NULL
present	NULL
only	NULL
in	NULL
stimulated	NULL
cells	NULL
or	NULL
after	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
Ets-1	NULL
by	NULL
purified	NULL
CaM	NULL
kinase	NULL
II	NULL
and	NULL
comprised	NULL
11-30	NULL
%	NULL
of	NULL
total	NULL
counts	NULL
in	NULL
the	NULL
protein	NULL
.	NULL

Peptide	NULL
2	NULL
phosphorylation	NULL
contributed	NULL
4-9	NULL
%	NULL
of	NULL
total	NULL
counts	NULL
in	NULL
Ets-1	NULL
from	NULL
stimulated	NULL
cells	NULL
;	NULL
peptide	NULL
3	NULL
had	NULL
35	NULL
,	NULL
19	NULL
,	NULL
and	NULL
34	NULL
%	NULL
of	NULL
total	NULL
label	NULL
incorporated	NULL
into	NULL
Ets-1	NULL
from	NULL
anti-IgM-	NULL
,	NULL
ionomycin-	NULL
,	NULL
or	NULL
CaM	NULL
kinase	NULL
II-treated	NULL
samples	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Peptides	NULL
1-3	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
plates	NULL
of	NULL
proteins	NULL
from	NULL
anti-IgM-	NULL
,	NULL
ionomycin-	NULL
,	NULL
or	NULL
CaM	NULL
kinase	NULL
-treated	NULL
cells	NULL
.	NULL

After	NULL
Cerenkov	NULL
counting	NULL
,	NULL
equal	NULL
cpm	NULL
from	NULL
each	NULL
treatment	NULL
for	NULL
each	NULL
peptide	NULL
were	NULL
combined	NULL
and	NULL
reanalyzed	NULL
in	NULL
two	NULL
dimensions	NULL
.	NULL

immunoprecipitated	NULL
Ets-1	NULL
protein	NULL
was	NULL
incubated	NULL
in	NULL
vitro	NULL
with	NULL
purified	NULL
CaM	NULL
kinase	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
bottom	NULL
right	NULL
)	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
peptide	NULL
phosphorylation	NULL
appeared	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
Ets-1	NULL
peptides	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-IgM	NULL
or	NULL
ionomycin	NULL
.	NULL

None	NULL
of	NULL
the	NULL
phosphopeptides	NULL
comigrated	NULL
with	NULL
free	NULL
phosphate	NULL
or	NULL
ATP	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
three	NULL
peptides	NULL
having	NULL
increased	NULL
phosphorylation	NULL
was	NULL
confirmed	NULL
by	NULL
removing	NULL
them	NULL
from	NULL
the	NULL
plates	NULL
and	NULL
mixing	NULL
equal	NULL
cpm	NULL
of	NULL
each	NULL
peptide	NULL
from	NULL
the	NULL
anti-IgM	NULL
,	NULL
ionomycin	NULL
,	NULL
or	NULL
CaM	NULL
kinase	NULL
II	NULL
plates	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

In	NULL
all	NULL
three	NULL
instances	NULL
,	NULL
the	NULL
mixtures	NULL
migrated	NULL
as	NULL
a	NULL
single	NULL
phosphopeptide	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
Ets-1	NULL
protein	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
CaM	NULL
kinase	NULL
II	NULL
and	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
phosphopeptides	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
with	NULL
the	NULL
purified	NULL
enzyme	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
those	NULL
stimuli	NULL
that	NULL
increase	NULL
levels	NULL
of	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Anti-IgM	NULL
Induces	NULL
CaM	NULL
Kinase	NULL
Activity	NULL
in	NULL
Human	NULL
B	NULL
Cells	NULL
.	NULL

To	NULL
test	NULL
for	NULL
anti-IgM-induced	NULL
activation	NULL
of	NULL
a	NULL
CaM	NULL
kinase	NULL
,	NULL
we	NULL
prepared	NULL
cell	NULL
extracts	NULL
from	NULL
the	NULL
Raji	NULL
or	NULL
T5-1	NULL
cells	NULL
and	NULL
measured	NULL
phosphorylation	NULL
of	NULL
the	NULL
peptide	NULL
substrate	NULL
,	NULL
syntide	NULL
.	NULL

Whereas	NULL
both	NULL
CaM	NULL
kinase	NULL
II	NULL
and	NULL
CaM	NULL
kinase	NULL
IV	NULL
can	NULL
use	NULL
syn-	NULL
tide	NULL
as	NULL
substrate	NULL
,	NULL
CaM	NULL
kinase	NULL
II	NULL
uses	NULL
syntide	NULL
as	NULL
substrate	NULL
about	NULL
10X	NULL
more	NULL
efficiently	NULL
than	NULL
does	NULL
CaM	NULL
kinase	NULL
IV	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
incorporated	NULL
into	NULL
the	NULL
assay	NULL
the	NULL
inhibitor	NULL
KN-62	NULL
,	NULL
which	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
calmodulin-binding	NULL
region	NULL
of	NULL
several	NULL
members	NULL
of	NULL
the	NULL
CaM	NULL
kinase	NULL
family	NULL
.	NULL

A	NULL
second	NULL
inhibitor	NULL
,	NULL
a	NULL
peptide	NULL
having	NULL
the	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
autoinhibitory	NULL
domain	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
(	NULL
«	NULL
subunit	NULL
residues	NULL
281-309	NULL
)	NULL
(	NULL
11	NULL
)	NULL
,	NULL
was	NULL
also	NULL
used	NULL
.	NULL

In	NULL
several	NULL
experiments	NULL
,	NULL
addition	NULL
of	NULL
ionomycin	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
anti~-IgM	NULL
to	NULL
the	NULL
cells	NULL
stimulated	NULL
the	NULL
rate	NULL
of	NULL
phosphorylation	NULL
of	NULL
syntide	NULL
by	NULL
1.4-2.5-fold	NULL
above	NULL
basal	NULL
levels	NULL
.	NULL

This	NULL
increase	NULL
was	NULL
reduced	NULL
by	NULL
both	NULL
inhibitors	NULL
at	NULL
the	NULL
early	NULL
time	NULL
points	NULL
,	NULL
suggesting	NULL
that	NULL
CaM	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
was	NULL
activated	NULL
by	NULL
these	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
Raji	NULL
cell	NULL
line	NULL
and	NULL
resting	NULL
(	NULL
dense	NULL
)	NULL
or	NULL
activated	NULL
(	NULL
buoyant	NULL
)	NULL
human	NULL
tonsilar	NULL
B	NULL
cells	NULL
.	NULL

Anti-IgM	NULL
induced	NULL
a	NULL
two-fold	NULL
increase	NULL
of	NULL
syntide	NULL
phosphorylation	NULL
in	NULL
the	NULL
Raji	NULL
cells	NULL
and	NULL
from	NULL
two-	NULL
to	NULL
fourfold	NULL
increases	NULL
in	NULL
tonsilar	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
addition	NULL
of	NULL
calcium	NULL
(	NULL
0.5	NULL
mM	NULL
)	NULL
into	NULL
the	NULL
reaction	NULL
mix	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
anti-IgM-	NULL
or	NULL
ionomycin-treated	NULL
samples	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
CaM	NULL
kinase	NULL
was	NULL
rapidly	NULL
activated	NULL
by	NULL
increased	NULL
calcium	NULL
levels	NULL
at	NULL
these	NULL
early	NULL
time	NULL
points	NULL
.	NULL

Anti-IgM	NULL
Increases	NULL
a	NULL
CaM	NULL
Kinase	NULL
Activity	NULL
in	NULL
the	NULL
Nucleus	NULL
.	NULL

-	NULL
As	NULL
the	NULL
data	NULL
were	NULL
consistent	NULL
with	NULL
anti-IgM-induced	NULL
activation	NULL
of	NULL
CaM	NULL
kinase	NULL
in	NULL
parallel	NULL
with	NULL
phosphorylation	NULL
of	NULL
Ets-1	NULL
,	NULL
we	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
Raji	NULL
or	NULL
T5-1	NULL
cells	NULL
incubated	NULL
with	NULL
anti-IgM	NULL
or	NULL
medium	NULL
and	NULL
assayed	NULL
for	NULL
phosphorylation	NULL
of	NULL
syntide	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
inhibitor	NULL
KN-62	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
presents	NULL
results	NULL
for	NULL
the	NULL
Raji	NULL
cells	NULL
in	NULL
which	NULL
anti-IgM-induced	NULL
phosphorylation	NULL
of	NULL
syntide	NULL
was	NULL
almost	NULL
exclusively	NULL
nu-clear	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
kinase	NULL
activity	NULL
was	NULL
inhibited	NULL
by	NULL
KN-62	NULL
&	NULL
@	NULL
2	NULL
a.	NULL
u	NULL
£	NULL
£	NULL
3	NULL
B	NULL
€	NULL
a	NULL
300	NULL
[	NULL
ifr	NULL
r	NULL
r	NULL
--	NULL
p	NULL
o	NULL
2	NULL
4	NULL
ION	NULL
8	NULL
Anti-u	NULL
stimulation	NULL
,	NULL
min	NULL
.	NULL

Figure	NULL
2	NULL
.	NULL

-	NULL
Anti-IgM-induced	NULL
phosphorylation	NULL
of	NULL
syntide	NULL
is	NULL
inhibited	NULL
by	NULL
KN-62	NULL
.	NULL

T5-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
or	NULL
with	NULL
anti-IgM	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
.	NULL

Other	NULL
T5-1	NULL
cells	NULL
were	NULL
also	NULL
incubated	NULL
with	NULL
ionomycin	NULL
(	NULL
1	NULL
M	NULL
)	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
syntide	NULL
phosphorylation	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
20	NULL
uM	NULL
inhibitor	NULL
peptide	NULL
or	NULL
10	NULL
M	NULL
KN-62	NULL
.	NULL

The	NULL
time	NULL
and	NULL
amount	NULL
of	NULL
extract	NULL
used	NULL
for	NULL
T5-1	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
linear	NULL
for	NULL
syntide	NULL
phosphorylation	NULL
by	NULL
previous	NULL
assay	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
results	NULL
from	NULL
four	NULL
to	NULL
six	NULL
replicate	NULL
experiments	NULL
,	NULL
and	NULL
phosphate	NULL
incorporation	NULL
is	NULL
given	NULL
as	NULL
picomoles/minute	NULL
per	NULL
milligram	NULL
of	NULL
total	NULL
protein	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
Raji	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

-R-	NULL
,	NULL
anti-u	NULL
,	NULL
-A-	NULL
,	NULL
peptide	NULL
,	NULL
~	NULL
}	NULL
,	NULL
KN-62	NULL
.	NULL

1946	NULL
5	NULL
€	NULL
5	NULL
8s	NULL
5f	NULL
2	NULL
a	NULL
6	NULL
&	NULL
£56	NULL
``	NULL
€	NULL
$	NULL
5	NULL
#	NULL
o	NULL
5	NULL
E	NULL
©	NULL
o	NULL
.	NULL

20	NULL
time	NULL
,	NULL
minutes	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Anti-IgM	NULL
induces	NULL
CaM	NULL
kinase	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Nu	NULL
clear	NULL
or	NULL
cytosolic	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
Raji	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
medium	NULL
alone	NULL
or	NULL
with	NULL
50	NULL
wg/tal	NULL
anti-igM	NULL
.	NULL

Phosphorylation	NULL
of	NULL
syntide	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
M	NULL
KN-62	NULL
,	NULL
and	NULL
values	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
assays	NULL
from	NULL
duplicate	NULL
samples	NULL
for	NULL
each	NULL
time	NULL
point	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
for	NULL
Raji	NULL
(	NULL
or	NULL
T5-1	NULL
)	NULL
cells	NULL
.	NULL

<	NULL
BR-	NULL
,	NULL
nu-clear-anti-p	NULL
,	NULL
-	NULL
&	NULL
~-	NULL
,	NULL
nuclear	NULL
+	NULL
KN62	NULL
,	NULL
-	NULL
}	NULL
-	NULL
,	NULL
cytosol-anti-u	NULL
,	NULL
-A-	NULL
,	NULL
cy-tosol	NULL
+	NULL
KN62	NULL
.	NULL

at	NULL
the	NULL
early	NULL
time	NULL
points	NULL
.	NULL

Cytosolic	NULL
extracts	NULL
routinely	NULL
had	NULL
one-third	NULL
to	NULL
one-eighth	NULL
the	NULL
activity	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
activity	NULL
changed	NULL
minimally	NULL
in	NULL
extracts	NULL
prepared	NULL
from	NULL
anti-IgM-stimulated	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
using	NULL
the	NULL
T5-1	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
increased	NULL
syntide	NULL
phosphorylation	NULL
as	NULL
induced	NULL
by	NULL
ionomycin	NULL
or	NULL
anti-IgM	NULL
was	NULL
reduced	NULL
to	NULL
unstimulated	NULL
levels	NULL
by	NULL
preincubation	NULL
(	NULL
1	NULL
h	NULL
)	NULL
of	NULL
cells	NULL
with	NULL
10	NULL
M	NULL
KN-62	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
ligation	NULL
of	NULL
surface	NULL
IgM	NULL
can	NULL
induce	NULL
CaM	NULL
kinase	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
this	NULL
activation	NULL
is	NULL
sensitive	NULL
shortly	NULL
after	NULL
stimulus	NULL
to	NULL
an	NULL
inhibitor	NULL
that	NULL
competes	NULL
with	NULL
calmodulin-binding	NULL
sites	NULL
.	NULL

CaM	NULL
Kinase	NULL
II	NULL
and	NULL
the	NULL
Ets-1	NULL
Proteins	NULL
in	NULL
the	NULL
Nucleus	NULL
in	NULL
Raji	NULL
Cells	NULL
.	NULL

The	NULL
above	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
activation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
membets	NULL
of	NULL
the	NULL
family	NULL
of	NULL
CaM	NULL
kinases	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
responsive	NULL
cells	NULL
.	NULL

Delcayre	NULL
et	NULL
al	NULL
.	NULL

have	NULL
previously	NULL
reported	NULL
the	NULL
presence	NULL
of	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
Raji	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
which	NULL
CaM	NULL
kinase	NULL
was	NULL
activated	NULL
,	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
were	NULL
probed	NULL
using	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
CaM	NULL
kinase	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
proteins	NULL
from	NULL
the	NULL
extracts	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
PVDF	NULL
membrane	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
antibody	NULL
.	NULL

We	NULL
found	NULL
that	NULL
CaM	NULL
kinase	NULL
II	NULL
was	NULL
present	NULL
almost	NULL
exclusively	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
migrated	NULL
similarly	NULL
to	NULL
the	NULL
48-and	NULL
60-kD	NULL
subunits	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
isolated	NULL
from	NULL
rat	NULL
brain	NULL
(	NULL
latter	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
higher	NULL
molecular	NULL
mass	NULL
protein	NULL
is	NULL
unknown	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
T5-1	NULL
cell	NULL
line	NULL
.	NULL

There	NULL
is	NULL
minimal	NULL
information	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
other	NULL
CaM	NULL
kinase	NULL
family	NULL
members	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

CaM	NULL
kinases	NULL
I	NULL
and	NULL
III	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
almost	NULL
exclusively	NULL
cytosolic	NULL
;	NULL
whereas	NULL
significant	NULL
levels	NULL
of	NULL
CaM	NULL
kinase	NULL
IV	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
this	NULL
isoform	NULL
is	NULL
not	NULL
ex	NULL
Anti-IgM	NULL
Activation	NULL
of	NULL
Nuclear	NULL
CaM	NULL
Kinase	NULL
II	NULL
_	NULL
Cyt	NULL
_	NULL
_Nuc	NULL
é	NULL
Cyt	NULL
___	NULL
Nuc	NULL
0	NULL
+	NULL
0	NULL
&	NULL
8	NULL
0	NULL
+00	NULL
+	NULL
a-y	NULL
200	NULL
same	NULL
.	NULL

**	NULL
``	NULL
al	NULL
97	NULL
wat	NULL
<	NULL
-	NULL
Some	NULL
:	NULL
wane	NULL
~4~-	NULL
al	NULL
(	NULL
*~	NULL
43	NULL
-29	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Both	NULL
CaM	NULL
kinase	NULL
II	NULL
and	NULL
the	NULL
Ets-1	NULL
proteins	NULL
are	NULL
predominantly	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
used	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
PVDF	NULL
membrane	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
either	NULL
CaM	NULL
kinase	NULL
II	NULL
(	NULL
4	NULL
)	NULL
or	NULL
the	NULL
Ets-1	NULL
protein	NULL
(	NULL
B	NULL
)	NULL
followed	NULL
by	NULL
'*I-protein	NULL
A.	NULL
Immunoreactive	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
after	NULL
48-h	NULL
exposure	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
migration	NULL
of	NULL
rat	NULL
brain	NULL
48-	NULL
and	NULL
60-kD	NULL
CaM	NULL
kinase	NULL
II	NULL
subunits	NULL
and	NULL
the	NULL
54-kD	NULL
Ets-1	NULL
protein	NULL
from	NULL
cells	NULL
incubated	NULL
in	NULL
medium	NULL
or	NULL
with	NULL
anti-IgM	NULL
(	NULL
-p	NULL
)	NULL
.	NULL

pressed	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Blotting	NULL
experiments	NULL
were	NULL
repeated	NULL
using	NULL
equal	NULL
amounts	NULL
of	NULL
proteins	NULL
from	NULL
the	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
of	NULL
Raji	NULL
cells	NULL
,	NULL
probing	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Ets-1	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

The	NULL
54-kD	NULL
Ets-1	NULL
protein	NULL
was	NULL
found	NULL
predominantly	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
the	NULL
Raji	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
previous	NULL
results	NULL
from	NULL
murine	NULL
B	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
,	NULL
migration	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
in	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
was	NULL
not	NULL
markedly	NULL
changed	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
both	NULL
CaM	NULL
kinase	NULL
II	NULL
and	NULL
the	NULL
Ets-1	NULL
protein	NULL
,	NULL
a	NULL
putative	NULL
substrate	NULL
,	NULL
are	NULL
localized	NULL
to	NULL
the	NULL
nuclear	NULL
compartment	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Preadsorption	NULL
with	NULL
Anti-CaM	NULL
Kinase	NULL
II	NULL
Antibodies	NULL
Reduces	NULL
Anti-IgM-induced	NULL
Syntide	NULL
Phosphorylation	NULL
in	NULL
Nuclear	NULL
Extracts	NULL
.	NULL

To	NULL
demonstrate	NULL
formally	NULL
that	NULL
the	NULL
kinase	NULL
activated	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
anti-IgM-treated	NULL
cells	NULL
is	NULL
CaM	NULL
kinase	NULL
II	NULL
,	NULL
we	NULL
incubated	NULL
the	NULL
nuclear	NULL
extracts	NULL
with	NULL
anti-CaM	NULL
kinase	NULL
II	NULL
antibody	NULL
before	NULL
assaying	NULL
for	NULL
syntide	NULL
phosphorylation	NULL
.	NULL

Extracts	NULL
were	NULL
aliquoted	NULL
to	NULL
receive	NULL
no	NULL
treatment	NULL
(	NULL
untreated	NULL
)	NULL
,	NULL
the	NULL
anti-CaM	NULL
kinase	NULL
II	NULL
antibody	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
CaM	NULL
kinase	NULL
II	NULL
adsorbed	NULL
)	NULL
,	NULL
or	NULL
BSA	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
BSA/	NULL
Sepharose	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
Sepharose	NULL
beads	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
samples	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
syntide	NULL
phosphorylation	NULL
.	NULL

We	NULL
found	NULL
~5-14	NULL
%	NULL
reduction	NULL
of	NULL
syntide	NULL
phosphorylation	NULL
in	NULL
extracts	NULL
incubated	NULL
with	NULL
BSA/Sepharose	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
dilutional	NULL
effect	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
adsorption	NULL
with	NULL
the	NULL
anti-CaM	NULL
kinase	NULL
II	NULL
antibody	NULL
resulted	NULL
in	NULL
46-66	NULL
%	NULL
decrease	NULL
of	NULL
anti-IgM-induced	NULL
phosphorylation	NULL
.	NULL

Immunoad-sorption	NULL
also	NULL
decreased	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
basal	NULL
activity	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
anti-IgM	NULL
induction	NULL
of	NULL
nuclear	NULL
CaM	NULL
kinase	NULL
II	NULL
activity	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

As	NULL
KN-62	NULL
treatment	NULL
of	NULL
cells	NULL
could	NULL
inhibit	NULL
CaM	NULL
kinase	NULL
activity	NULL
only	NULL
at	NULL
the	NULL
early	NULL
time	NULL
points	NULL
after	NULL
anti-IgM	NULL
,	NULL
our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
calcium-independent	NULL
form	NULL
of	NULL
the	NULL
kinase	NULL
in	NULL
untreated	NULL
cells	NULL
and	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
anti-IgM	NULL
at	NULL
the	NULL
later	NULL
time	NULL
points	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
after	NULL
adsorption	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
to	NULL
the	NULL
Sepharose	NULL
beads	NULL
,	NULL
we	NULL
assayed	NULL
for	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
protein	NULL
.	NULL

Whereas	NULL
we	NULL
found	NULL
both	NULL
48-	NULL
and	NULL
60-kD	NULL
proteins	NULL
present	NULL
by	NULL
immunoblotting	NULL
.	NULL

we	NULL
were	NULL
never	NULL
able	NULL
to	NULL
recover	NULL
kinase	NULL
activity	NULL
in	NULL
the	NULL
immu-	NULL
1947	NULL
Valentine	NULL
et	NULL
al	NULL
.	NULL

600	NULL
-r	NULL
'D~~~	NULL
a	NULL
*~	NULL
#	NULL
``	NULL
~	NULL
,	NULL
»	NULL
*~	NULL
#	NULL
~~	NULL
500	NULL
Fy	NULL
``	NULL
~	NULL
.	NULL

#	NULL
B	NULL
-*	NULL
5	NULL
y	NULL
we	NULL
3	NULL
40	NULL
»	NULL
*	NULL
Post	NULL
-J	NULL
E	NULL
€	NULL
E	NULL
c	NULL
E	NULL
-a	NULL
100	NULL
-t	NULL
y	NULL
t	NULL
y	NULL
t	NULL
r	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
minutes	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Adsorption	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
activity	NULL
from	NULL
nuclear	NULL
extracts	NULL
.	NULL

Raji	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
or	NULL
anti-IgM	NULL
for	NULL
5	NULL
or	NULL
10	NULL
min	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
the	NULL
extracts	NULL
were	NULL
aliquoted	NULL
for	NULL
the	NULL
following	NULL
treatments	NULL
:	NULL
(	NULL
a	NULL
)	NULL
no	NULL
treatment	NULL
;	NULL
(	NULL
b	NULL
)	NULL
incubation	NULL
with	NULL
anti-CaM	NULL
kinase	NULL
II	NULL
(	NULL
6	NULL
pg	NULL
)	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
4°C	NULL
,	NULL
30	NULL
min	NULL
)	NULL
;	NULL
or	NULL
(	NULL
c	NULL
)	NULL
incubation	NULL
with	NULL
BSA	NULL
(	NULL
6	NULL
pg	NULL
)	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
Sepharose	NULL
beads	NULL
were	NULL
pelleted	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
syntide	NULL
phosphorylation	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
percent	NULL
cpm	NULL
for	NULL
0	NULL
min	NULL
(	NULL
untreated	NULL
=	NULL
23,941	NULL
cpm	NULL
)	NULL
,	NULL
5	NULL
min	NULL
with	NULL
anti-IgM	NULL
(	NULL
untreated	NULL
=	NULL
39,124	NULL
cpm	NULL
)	NULL
,	NULL
and	NULL
10	NULL
min	NULL
with	NULL
anti-IgM	NULL
(	NULL
untreated	NULL
=	NULL
37,219	NULL
cpm	NULL
)	NULL
samples	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
each	NULL
of	NULL
three	NULL
replicate	NULL
experiments	NULL
.	NULL

-	NULL
}	NULL
-	NULL
,	NULL
untreated	NULL
,	NULL
-	NULL
&	NULL
-	NULL
,	NULL
CaM	NULL
KI	NULL
adsorbed	NULL
,	NULL
-C-	NULL
,	NULL
BSA/Sepharose	NULL
.	NULL

noprecipitates	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
calcium/	NULL
calmodulin	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
experience	NULL
with	NULL
several	NULL
antibodies	NULL
directed	NULL
against	NULL
some	NULL
PKC	NULL
isoforms	NULL
,	NULL
however	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
antibody	NULL
to	NULL
maintain	NULL
enzymatic	NULL
activity	NULL
may	NULL
be	NULL
due	NULL
to	NULL
irreversible	NULL
denaturation	NULL
induced	NULL
during	NULL
immunoprecipitation	NULL
.	NULL

Discussion	NULL
Activation	NULL
of	NULL
signaling	NULL
pathways	NULL
by	NULL
ligation	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
is	NULL
amplified	NULL
by	NULL
several	NULL
protein	NULL
serine/threonine	NULL
kinases	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
dependent	NULL
on	NULL
second	NULL
messengers	NULL
for	NULL
activation	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
5	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Ligation	NULL
of	NULL
surface	NULL
IgM	NULL
leads	NULL
to	NULL
a	NULL
rapid	NULL
increase	NULL
of	NULL
the	NULL
second	NULL
messenger	NULL
calcium	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
can	NULL
activate	NULL
numerous	NULL
calcium-dependent	NULL
enzymes	NULL
,	NULL
including	NULL
the	NULL
CaM	NULL
kinases	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
nuclear	NULL
protein	NULL
kinase	NULL
activity	NULL
is	NULL
stimulated	NULL
in	NULL
response	NULL
to	NULL
anti-IgM	NULL
or	NULL
ionomycin	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

CaM	NULL
kinase	NULL
II	NULL
appears	NULL
to	NULL
account	NULL
for	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
nuclear	NULL
protein	NULL
kinase	NULL
activity	NULL
that	NULL
is	NULL
stimulated	NULL
by	NULL
anti-IgM	NULL
ligation	NULL
as	NULL
judged	NULL
by	NULL
(	NULL
a	NULL
)	NULL
the	NULL
presence	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
in	NULL
the	NULL
nucleus	NULL
;	NULL
(	NULL
b	NULL
)	NULL
induction	NULL
of	NULL
phosphorylation	NULL
on	NULL
syntide	NULL
,	NULL
which	NULL
was	NULL
inhibitable	NULL
by	NULL
KN-62	NULL
;	NULL
and	NULL
,	NULL
most	NULL
compellingly	NULL
,	NULL
(	NULL
¢	NULL
)	NULL
reduction	NULL
of	NULL
nuclear	NULL
protein	NULL
kinase	NULL
activity	NULL
by	NULL
preadsorption	NULL
with	NULL
anti-CaM	NULL
kinase	NULL
II	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
inhibitor	NULL
KN-62	NULL
has	NULL
no	NULL
measurable	NULL
activity	NULL
on	NULL
MLCK	NULL
,	NULL
PKC	NULL
,	NULL
or	NULL
PKA	NULL
type	NULL
II	NULL
(	NULL
11	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Whereas	NULL
KN-62	NULL
can	NULL
inhibit	NULL
the	NULL
calcium/calmodulin	NULL
activation	NULL
of	NULL
CaM	NULL
kinase	NULL
II	NULL
,	NULL
once	NULL
the	NULL
kinase	NULL
is	NULL
autophosphorylated	NULL
and	NULL
converted	NULL
to	NULL
a	NULL
calcium-independent	NULL
form	NULL
(	NULL
for	NULL
review	NULL
see	NULL
reference	NULL
25	NULL
)	NULL
,	NULL
KN-62	NULL
has	NULL
little	NULL
effect	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
this	NULL
mechanism	NULL
,	NULL
the	NULL
rapid	NULL
anti-IgM-induced	NULL
phosphorylation	NULL
of	NULL
syntide	NULL
in	NULL
both	NULL
the	NULL
Raji	NULL
and	NULL
T5-1	NULL
cells	NULL
was	NULL
almost	NULL
totally	NULL
ablated	NULL
by	NULL
addition	NULL
of	NULL
KN-62	NULL
to	NULL
the	NULL
extracts	NULL
only	NULL
at	NULL
the	NULL
early	NULL
time	NULL
points	NULL
,	NULL
implying	NULL
that	NULL
CaM	NULL
kinase	NULL
I	NULL
was	NULL
not	NULL
autophosphorylated	NULL
at	NULL
these	NULL
early	NULL
time	NULL
points	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
anti-IgM-induced	NULL
CaM	NULL
kinase	NULL
II	NULL
activity	NULL
was	NULL
only	NULL
partially	NULL
inhibited	NULL
by	NULL
KN-62	NULL
after	NULL
10-15-min	NULL
stimulation	NULL
of	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
normal	NULL
tonsilar	NULL
B	NULL
cells	NULL
(	NULL
Valentine	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

As	NULL
the	NULL
induced	NULL
protein	NULL
kinase	NULL
activity	NULL
was	NULL
adsorbed	NULL
by	NULL
anti-CaM	NULL
kinase	NULL
II	NULL
antibodies	NULL
at	NULL
10	NULL
min	NULL
,	NULL
this	NULL
suggests	NULL
that	NULL
CaM	NULL
kinase	NULL
II	NULL
became	NULL
autophosphorylated	NULL
(	NULL
and	NULL
resistant	NULL
to	NULL
inhibition	NULL
by	NULL
KN-62	NULL
)	NULL
later	NULL
in	NULL
stimulation	NULL
.	NULL

A	NULL
current	NULL
model	NULL
for	NULL
CaM	NULL
kinase	NULL
II	NULL
regulation	NULL
proposes	NULL
that	NULL
kinase	NULL
activation	NULL
leads	NULL
to	NULL
autophosphorylation	NULL
and	NULL
entrapment	NULL
of	NULL
calmodulin	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
pathway	NULL
initiated	NULL
by	NULL
ligation	NULL
of	NULL
surface	NULL
IgM	NULL
that	NULL
increases	NULL
calcium	NULL
levels	NULL
within	NULL
the	NULL
cell	NULL
and	NULL
rapidly	NULL
activates	NULL
nuclear	NULL
CaM	NULL
kinase	NULL
II	NULL
.	NULL

Nuclear	NULL
CaM	NULL
kinase	NULL
II	NULL
then	NULL
could	NULL
phosphorylate	NULL
the	NULL
Ets-1	NULL
protein	NULL
and	NULL
negatively	NULL
regulate	NULL
its	NULL
interaction	NULL
with	NULL
specific	NULL
enhancer	NULL
and	NULL
promoter	NULL
elements	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Nuclear	NULL
Ets	NULL
proteins	NULL
appear	NULL
to	NULL
exhibit	NULL
cooperative	NULL
effects	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
systems	NULL
,	NULL
including	NULL
the	NULL
induction	NULL
of	NULL
avian	NULL
erythroleukemia	NULL
through	NULL
association	NULL
with	NULL
v-erb	NULL
(	NULL
28	NULL
)	NULL
,	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
through	NULL
association	NULL
with	NULL
myb	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
stimulation	NULL
of	NULL
the	NULL
Ets-1	NULL
promoter	NULL
itself	NULL
(	NULL
30	NULL
)	NULL
.	NULL

At	NULL
least	NULL
two	NULL
examples	NULL
exist	NULL
in	NULL
which	NULL
CaM	NULL
kinases	NULL
have	NULL
been	NULL
linked	NULL
to	NULL
phosphorylation	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

Increased	NULL
transcription	NULL
was	NULL
effected	NULL
by	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
the	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
in	NULL
transfected	NULL
PC12	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
and	NULL
the	NULL
C/EBP-B	NULL
transcription	NULL
factor	NULL
in	NULL
a	NULL
transfected	NULL
rat	NULL
pituitary	NULL
cell	NULL
line	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
CaM	NULL
kinase	NULL
family	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
the	NULL
active	NULL
kinase	NULL
.	NULL

Our	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
these	NULL
reports	NULL
in	NULL
that	NULL
signals	NULL
that	NULL
increased	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
rapidly	NULL
activated	NULL
CaM	NULL
kinase	NULL
II	NULL
that	NULL
was	NULL
resident	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
the	NULL
mechanisms	NULL
that	NULL
dictate	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
protein	NULL
kinases	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
nuclear	NULL
proteins	NULL
that	NULL
function	NULL
in	NULL
a	NULL
fashion	NULL
similar	NULL
to	NULL
those	NULL
responsible	NULL
for	NULL
the	NULL
association	NULL
of	NULL
PKC	NULL
to	NULL
the	NULL
cytoskeleton	NULL
(	NULL
33	NULL
)	NULL
or	NULL
PKA	NULL
to	NULL
various	NULL
cellular	NULL
compartments	NULL
(	NULL
34	NULL
)	NULL
may	NULL
be	NULL
one	NULL
mechanism	NULL
to	NULL
direct	NULL
protein	NULL
kinases	NULL
to	NULL
their	NULL
appropriate	NULL
nuclear	NULL
substrates	NULL
.	NULL

Alternate	NULL
splicing	NULL
of	NULL
the	NULL
8/B	NULL
isoform	NULL
of	NULL
CaM	NULL
kinases	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
nuclear	NULL
targeting	NULL
of	NULL
the	NULL
kinase	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
both	NULL
CaM	NULL
kinase	NULL
II	NULL
and	NULL
its	NULL
potential	NULL
substrate	NULL
are	NULL
located	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
a	NULL
direct	NULL
link	NULL
between	NULL
increases	NULL
in	NULL
[	NULL
Ca®*	NULL
]	NULL
;	NULL
that	NULL
are	NULL
initiated	NULL
by	NULL
membrane	NULL
proteins	NULL
and	NULL
transcriptional	NULL
control	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

In	NULL
view	NULL
of	NULL
recent	NULL
reports	NULL
of	NULL
nuclear	NULL
calcium	NULL
transport	NULL
(	NULL
36	NULL
)	NULL
and	NULL
nuclear	NULL
calmodulin-protein	NULL
complexes	NULL
(	NULL
37	NULL
)	NULL
,	NULL
transcriptional	NULL
regulation	NULL
could	NULL
involve	NULL
direct	NULL
control	NULL
of	NULL
calcium-dependent	NULL
kinases	NULL
resident	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Edwin	NULL
Krebs	NULL
for	NULL
helpful	NULL
discussion	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
GM-42508	NULL
,	NULL
GM-45134	NULL
,	NULL
AlI-21768	NULL
,	NULL
and	NULL
Al-20519	NULL
and	NULL
the	NULL
Northwest	NULL
Kidney	NULL
Foundation	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Mary	NULL
A.	NULL
Valentine	NULL
at	NULL
her	NULL
current	NULL
address	NULL
:	NULL
5507	NULL
Ravena	NULL
Avenue	NULL
,	NULL
N.E	NULL
.	NULL

,	NULL
Seattle	NULL
,	NULL
WA	NULL
98105	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
12	NULL
April	NULL
1995	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
18	NULL
July	NULL
1994	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
.	NULL

70:375-387	NULL
.	NULL

2	NULL
.	NULL

Chen	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Sarnecki	NULL
,	NULL
and	NULL
J.	NULL
Blenis	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
localization	NULL
and	NULL
regulation	NULL
of	NULL
erk-	NULL
and	NULL
rsk-encoded	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:915-927	NULL
.	NULL

3	NULL
.	NULL

Fisher	NULL
,	NULL
CL	NULL
.	NULL

,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
and	NULL
J.C.	NULL
Cambier	NULL
.	NULL

1991	NULL
.	NULL

Ligation	NULL
of	NULL
membrane	NULL
Ig	NULL
leads	NULL
to	NULL
calcium-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
proto-oncogene	NULL
product	NULL
,	NULL
Ets-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1743-1749	NULL
.	NULL

4	NULL
.	NULL

Pogonec	NULL
,	NULL
P.	NULL
,	NULL
K.E	NULL
.	NULL

Boulukos	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
c-ets-1	NULL
protein	NULL
is	NULL
chromatin	NULL
associated	NULL
and	NULL
binds	NULL
DNA	NULL
in	NULL
vitro	NULL
.	NULL

Oncogene	NULL
.	NULL

4:691-697	NULL
.	NULL

5	NULL
.	NULL

Pogonec	NULL
,	NULL
P.	NULL
,	NULL
K.E	NULL
.	NULL

Boulukos	NULL
,	NULL
J.C.	NULL
Gesquiere	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1988	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
results	NULL
in	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
c-ets-1	NULL
proteins	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

7:977-983	NULL
.	NULL

6	NULL
.	NULL

Valentine	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
C.	NULL
Leprince	NULL
,	NULL
E.	NULL
Genot	NULL
,	NULL
K.E	NULL
,	NULL
.	NULL

Meier	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Clark	NULL
.	NULL

1993	NULL
.	NULL

Protein	NULL
kinases	NULL
in	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
Pro	NULL
1948	NULL
tein	NULL
Kinases	NULL
in	NULL
Blood	NULL
Cell	NULL
Function	NULL
.	NULL

C.	NULL
Huang	NULL
and	NULL
R1	NULL
.	NULL

Sha'afi	NULL
,	NULL
editors	NULL
.	NULL

CRC	NULL
Press	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
FL	NULL
.	NULL

1-48	NULL
.	NULL

7	NULL
.	NULL

Stull	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
M.H	NULL
.	NULL

Nunnally	NULL
,	NULL
and	NULL
C.H	NULL
.	NULL

Michnoff	NULL
.	NULL

1986	NULL
.	NULL

Calmodulin-dependent	NULL
protein	NULL
kinases	NULL
.	NULL

Enzymes	NULL
.	NULL

17:115-166	NULL
.	NULL

8	NULL
.	NULL

Benfenati	NULL
,	NULL
F.	NULL
,	NULL
F.	NULL
Valtorta	NULL
,	NULL
J.L	NULL
.	NULL

Rubenstein	NULL
,	NULL
F.S	NULL
.	NULL

Gorelick	NULL
,	NULL
P.	NULL
Greengard	NULL
,	NULL
and	NULL
A.J	NULL
.	NULL

Czernik	NULL
.	NULL

1992	NULL
.	NULL

Synaptic	NULL
vesicle-associated	NULL
Ca**/calmodulin	NULL
dependent	NULL
protein	NULL
kinase	NULL
II	NULL
is	NULL
a	NULL
binding	NULL
protein	NULL
for	NULL
synapsin	NULL
I	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

359:417-420	NULL
.	NULL

9	NULL
.	NULL

Hashimoto	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
TR	NULL
.	NULL

Soderling	NULL
.	NULL

1987	NULL
.	NULL

Phosphorylation	NULL
of	NULL
smooth	NULL
muscle	NULL
myosin	NULL
light	NULL
chain	NULL
kinase	NULL
by	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
:	NULL
comparative	NULL
study	NULL
of	NULL
the	NULL
phosphorylation	NULL
sites	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

252:418-425	NULL
.	NULL

10	NULL
.	NULL

Scott	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
M.B	NULL
.	NULL

Glaccum	NULL
,	NULL
E.H.	NULL
Fischer	NULL
,	NULL
and	NULL
E.G	NULL
.	NULL

Krebs	NULL
.	NULL

1986	NULL
.	NULL

Primary-structure	NULL
requirements	NULL
for	NULL
inhibition	NULL
by	NULL
the	NULL
heat-stable	NULL
inhibitor	NULL
of	NULL
the	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

83:1613-1616	NULL
.	NULL

11	NULL
.	NULL

Colbran	NULL
,	NULL
R.J.	NULL
,	NULL
MK	NULL
.	NULL

Smith	NULL
,	NULL
C.M	NULL
.	NULL

Schworer	NULL
,	NULL
Y.L	NULL
.	NULL

Fong	NULL
,	NULL
and	NULL
Anti-IgM	NULL
Activation	NULL
of	NULL
Nuclear	NULL
CaM	NULL
Kinase	NULL
II	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

T.R	NULL
.	NULL

Soderling	NULL
.	NULL

1989	NULL
.	NULL

Regulatory	NULL
domain	NULL
of	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
.	NULL

Mechanism	NULL
of	NULL
inhibition	NULL
and	NULL
regulation	NULL
by	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
:	NULL
4800-4804	NULL
.	NULL

McGuiness	NULL
,	NULL
TL	NULL
.	NULL

,	NULL
Y.	NULL
Lai	NULL
,	NULL
and	NULL
P.	NULL
Greengard	NULL
.	NULL

1985	NULL
.	NULL

Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
.	NULL

Isozymic	NULL
forms	NULL
from	NULL
rat	NULL
forebrain	NULL
and	NULL
cerebellum	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260:1696-1704	NULL
.	NULL

Tokumitsu	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Chijiwa	NULL
,	NULL
T.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
Mizutani	NULL
,	NULL
M.	NULL
Terasawa	NULL
,	NULL
and	NULL
H.	NULL
Hidaka	NULL
.	NULL

1990	NULL
.	NULL

KN-62	NULL
,	NULL
1-	NULL
[	NULL
N	NULL
,	NULL
O-bis	NULL
(	NULL
5-iso-quinolinesulfonyl	NULL
)	NULL
~-N-methyl-L-tyrosyl|l-4-phenylpiperazine	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:4315-4320	NULL
.	NULL

Valentine	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
K.E	NULL
.	NULL

Meier	NULL
,	NULL
S.	NULL
Rossie	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Clark	NULL
.	NULL

1989	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
CD20	NULL
molecule	NULL
in	NULL
resting	NULL
B	NULL
lymphocytes	NULL
:	NULL
regulation	NULL
by	NULL
protein	NULL
kinase	NULL
C.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:11282-11287	NULL
.	NULL

Laemmli	NULL
,	NULL
U.K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

227:680-685	NULL
.	NULL

Dignam	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
R.M	NULL
.	NULL

Lebovitz	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Genot	NULL
,	NULL
EM	NULL
.	NULL

,	NULL
K.E	NULL
.	NULL

Meier	NULL
,	NULL
K.A	NULL
.	NULL

Licciardi	NULL
,	NULL
N.G	NULL
.	NULL

Ahn	NULL
,	NULL
CH	NULL
.	NULL

Uittenbogaart	NULL
,	NULL
J.	NULL
Wietzerbin	NULL
,	NULL
E.A	NULL
.	NULL

Clark	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Valentine	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylation	NULL
of	NULL
CD20	NULL
in	NULL
cells	NULL
from	NULL
a	NULL
Hairy	NULL
cell	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

Evidence	NULL
for	NULL
involvement	NULL
of	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:71-82	NULL
.	NULL

Valentine	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
K.A	NULL
.	NULL

Licciardi	NULL
,	NULL
EA	NULL
.	NULL

Clark	NULL
,	NULL
E.G	NULL
.	NULL

Krebs	NULL
,	NULL
and	NULL
K.E	NULL
.	NULL

Meier	NULL
.	NULL

1993	NULL
.	NULL

Insulin	NULL
regulates	NULL
serine/threonine	NULL
phosphorylation	NULL
in	NULL
activated	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:96-105	NULL
.	NULL

Watson	NULL
,	NULL
D.K	NULL
.	NULL

,	NULL
M.J.	NULL
McWilliams	NULL
,	NULL
P.	NULL
Lapis	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lautenberger	NULL
,	NULL
C.W	NULL
.	NULL

Schweinfest	NULL
,	NULL
and	NULL
TS	NULL
.	NULL

Papas	NULL
.	NULL

1988	NULL
.	NULL

Mammalian	NULL
ets-1	NULL
and	NULL
ets-2	NULL
genes	NULL
encode	NULL
highly	NULL
conserved	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

85:7862-7866	NULL
.	NULL

Valentine	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
S.L	NULL
.	NULL

Bursten	NULL
,	NULL
W.E	NULL
.	NULL

Harris	NULL
,	NULL
K.E	NULL
.	NULL

Draves	NULL
,	NULL
B.A	NULL
.	NULL

Pollok	NULL
,	NULL
J.	NULL
Ostrowski	NULL
,	NULL
K.	NULL
Bomsztyk	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

Clark	NULL
.	NULL

1992	NULL
.	NULL

Generation	NULL
of	NULL
phosphatidic	NULL
acid	NULL
and	NULL
diacylglycerols	NULL
following	NULL
ligation	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
:	NULL
potential	NULL
role	NULL
in	NULL
PKC	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

141:373-387	NULL
.	NULL

Enslen	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Sun	NULL
,	NULL
D.	NULL
Brickey	NULL
,	NULL
S.H	NULL
.	NULL

Soderling	NULL
,	NULL
E.	NULL
Klamo	NULL
,	NULL
and	NULL
TR	NULL
.	NULL

Soderling	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
IV	NULL
.	NULL

Role	NULL
in	NULL
transcriptional	NULL
regula-tion	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:15520-15527	NULL
.	NULL

Delcayre	NULL
,	NULL
AX	NULL
.	NULL

,	NULL
A.	NULL
Fiandino	NULL
,	NULL
F.	NULL
Lyamani	NULL
,	NULL
M.	NULL
Barel	NULL
,	NULL
and	NULL
R.	NULL
Frade	NULL
.	NULL

1989	NULL
.	NULL

Enhancement	NULL
of	NULL
Epstein-Barr	NULL
virus/C3d	NULL
receptor	NULL
(	NULL
EBV/C3dR	NULL
or	NULL
CR2	NULL
)	NULL
and	NULL
nuclear	NULL
p120	NULL
ribonucleopro-tein	NULL
phosphorylation	NULL
by	NULL
specific	NULL
EBV/C3dR	NULL
ligands	NULL
in	NULL
sub-cellular	NULL
fraction	NULL
of	NULL
the	NULL
human	NULL
B	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
Raji	NULL
.	NULL

1949	NULL
Valentine	NULL
et	NULL
al	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

159:1213-1218	NULL
.	NULL

Hanissian	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
M.	NULL
Frangakis	NULL
,	NULL
M.M	NULL
.	NULL

Bland	NULL
,	NULL
S.	NULL
Jawhar	NULL
,	NULL
and	NULL
R.A.	NULL
Chatila	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
Ca	NULL
``	NULL
*/calmodulin-depen-dent	NULL
protein	NULL
kinase	NULL
,	NULL
CaM	NULL
kinase-Gr	NULL
,	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Regulation	NULL
of	NULL
kinase	NULL
activity	NULL
by	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:20055-20063	NULL
.	NULL

Cushley	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
M.M	NULL
.	NULL

Harnett	NULL
.	NULL

1993	NULL
.	NULL

Cellular	NULL
signaling	NULL
mechanisms	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

292:313-332	NULL
.	NULL

Hidaka	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
Kobayashi	NULL
.	NULL

1992	NULL
.	NULL

Pharmacology	NULL
of	NULL
protein	NULL
kinase	NULL
inhibitors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Pharmacol	NULL
.	NULL

Toxicol	NULL
.	NULL

32:377-397	NULL
.	NULL

Michelson	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
H.	NULL
Shulman	NULL
.	NULL

1994	NULL
.	NULL

CaM	NULL
kinase	NULL
:	NULL
a	NULL
model	NULL
for	NULL
its	NULL
activation	NULL
and	NULL
dynamics	NULL
.	NULL

J.	NULL
Theor	NULL
.	NULL

Biol	NULL
.	NULL

171:281-290	NULL
.	NULL

Hanson	NULL
,	NULL
PL	NULL
.	NULL

,	NULL
T.	NULL
Meyer	NULL
,	NULL
L.	NULL
Stryer	NULL
,	NULL
and	NULL
H.	NULL
Schulman	NULL
.	NULL

1994	NULL
.	NULL

Dual	NULL
role	NULL
of	NULL
calmodulin	NULL
in	NULL
autophosphorylation	NULL
of	NULL
multifunctional	NULL
CaM	NULL
kinase	NULL
may	NULL
underlie	NULL
decoding	NULL
of	NULL
calcium	NULL
signals	NULL
.	NULL

Neuron	NULL
.	NULL

12:943-956	NULL
.	NULL

Metz	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
TF	NULL
.	NULL

Graf	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
nuclear	NULL
oncogenes	NULL
v-erb	NULL
A	NULL
and	NULL
v-ets	NULL
cooperate	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
avian	NULL
erythroleuke-mia	NULL
.	NULL

Oncogene	NULL
.	NULL

7:597-605	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
R.V	NULL
.	NULL

Tantravahi	NULL
,	NULL
V.N	NULL
.	NULL

Rao	NULL
,	NULL
E.S.P	NULL
.	NULL

Reddy	NULL
,	NULL
and	NULL
E.P	NULL
.	NULL

Reddy	NULL
.	NULL

1992	NULL
.	NULL

Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:1291-1295	NULL
.	NULL

Majerus	NULL
,	NULL
M.-A	NULL
.	NULL

,	NULL
F.	NULL
Bibollet-Ruche	NULL
,	NULL
J.-B	NULL
.	NULL

Telliez	NULL
,	NULL
B.	NULL
Wasy-lyk	NULL
,	NULL
and	NULL
B.	NULL
Bailleul	NULL
.	NULL

1992	NULL
.	NULL

Serum	NULL
,	NULL
AP-1	NULL
and	NULL
Ets-1	NULL
stimulate	NULL
the	NULL
human	NULL
ets-1	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:2699-2703	NULL
.	NULL

Sheng	NULL
,	NULL
M.	NULL
,	NULL
M.A	NULL
.	NULL

Thompson	NULL
,	NULL
and	NULL
M.E	NULL
.	NULL

Greenberg	NULL
.	NULL

1991	NULL
.	NULL

CREB	NULL
:	NULL
A	NULL
Ca**-regulated	NULL
transcription	NULL
factor	NULL
phosphorylated	NULL
by	NULL
calmodulin-dependent	NULL
kinases	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

252	NULL
:	NULL
1427-1430.	NULL
.	NULL

Wegner	NULL
,	NULL
M.	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
and	NULL
M.G	NULL
.	NULL

Rosenfeld	NULL
.	NULL

1992	NULL
.	NULL

Calcium	NULL
regulated	NULL
phosphorylation	NULL
within	NULL
the	NULL
leucine	NULL
zipper	NULL
of	NULL
C/	NULL
EBPB	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

256:370-373	NULL
.	NULL

Ron	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
D.	NULL
Mochly-Rosen	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
autoregulatory	NULL
region	NULL
in	NULL
protein	NULL
kinase	NULL
C	NULL
:	NULL
the	NULL
pseudoanchoring	NULL
site	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

92:492-496	NULL
.	NULL

Scott	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
and	NULL
S.	NULL
McCartney	NULL
,	NULL
1994	NULL
.	NULL

Localization	NULL
of	NULL
A-kinase	NULL
through	NULL
anchoring	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

8:5-11	NULL
.	NULL

Srinivasan	NULL
,	NULL
M.	NULL
,	NULL
C.F	NULL
.	NULL

Edman	NULL
,	NULL
and	NULL
H.	NULL
Schulman	NULL
.	NULL

1994	NULL
.	NULL

Alternative	NULL
splicing	NULL
introduces	NULL
a	NULL
nuclear	NULL
localization	NULL
signal	NULL
that	NULL
targets	NULL
multifunctional	NULL
CaM	NULL
kinase	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

126	NULL
:	NULL
839-852	NULL
.	NULL

Nicoter	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Zhivotovksy	NULL
,	NULL
and	NULL
S.	NULL
Orrenius	NULL
.	NULL

1994	NULL
.	NULL

Nuclear	NULL
calcium	NULL
transport	NULL
and	NULL
the	NULL
role	NULL
of	NULL
calcium	NULL
in	NULL
apoptosis	NULL
.	NULL

Cell	NULL
Cakium	NULL
.	NULL

16:279-288	NULL
.	NULL

Portoles	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Faura	NULL
,	NULL
J.	NULL
Renau-Piqueras	NULL
,	NULL
FJ	NULL
.	NULL

Iborra	NULL
,	NULL
R.	NULL
Saez	NULL
,	NULL
C.	NULL
Guerri	NULL
,	NULL
J.	NULL
Serratosa	NULL
,	NULL
E.	NULL
Rius	NULL
,	NULL
and	NULL
O.	NULL
Bachs	NULL
.	NULL

1994	NULL
.	NULL

Nuclear	NULL
calmodulin/62	NULL
kDa	NULL
calmodulin-binding	NULL
protein	NULL
complexes	NULL
in	NULL
interphasic	NULL
and	NULL
mitotic	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sa	NULL
.	NULL

107:3601-3614	NULL
.	NULL

